Question

Difficulty: HardInfection Control and Hospital-Acquired Conditions

A hospital's infection control and quality improvement committee is reviewing an unexpected 40% increase in the facility's reported rate of hospital-onset Clostridioides difficile infection (HO-CDI) over the past quarter. A root cause analysis of the recent cases reveals that 55% of the patients who tested positive had fewer than three unformed stools in a 24-hour period, and 45% had been administered bowel preparations or osmotic laxatives within the 48 hours preceding the test. The hospital microbiology laboratory currently utilizes a highly sensitive, standalone nucleic acid amplification test (NAAT) for C. difficile on all submitted stool specimens. Which of the following systemic interventions is the most appropriate next step to accurately reflect the true infection rate and improve patient safety?

  1. A
    Transition the microbiology laboratory protocol to a standalone enzyme immunoassay for glutamate dehydrogenase
  2. B
    Require infectious disease consultation prior to initiating targeted therapy for patients with a positive stool test
  3. C
    Initiate empiric oral vancomycin prophylaxis for all hospitalized patients receiving broad-spectrum intravenous antibiotics
  4. D
    Institute a policy requiring the isolation of all patients with positive stool test results in negative-pressure rooms
  5. Implement an electronic medical record hard-stop preventing testing in patients with recent laxative administrationAnswer

Answer

Implement an electronic medical record hard-stop preventing testing in patients with recent laxative administration
The correct intervention targets the root cause of the inflated infection rate: poor diagnostic stewardship. Clostridioides difficile NAAT is highly sensitive and detects the genetic material of the organism, but it cannot differentiate between active infection and asymptomatic colonization. Clinical guidelines mandate that testing should only be performed on patients with unexplained and new-onset unformed stools (typically ≥\geq 3 in 24 hours). Testing patients who have recently received laxatives leads to the detection of asymptomatic carriers. Implementing an electronic medical record (EMR) hard-stop directly prevents this inappropriate testing upstream, reducing unnecessary antibiotic exposure, preventing the misclassification of colonization as active disease, and accurately reflecting true HO-CDI rates.

Step-by-Step Solution

1
Analyze the root cause findings provided by the infection control committee.
The increase in HO-CDI rates is driven by testing patients with inadequate symptom criteria (fewer than 3 unformed stools) or alternative causes for diarrhea (recent laxative use).
Identifying the specific systemic failure is required before selecting a targeted intervention.
2
Evaluate the current diagnostic testing modality.
The hospital uses a standalone NAAT, which is highly sensitive for detecting the presence of the C. difficile gene but cannot distinguish between active toxin-producing infection and asymptomatic colonization.
Understanding the limitations of NAAT highlights why testing appropriate patients (high pre-test probability) is critical.
3
Select the intervention that targets the root cause upstream.
An electronic medical record hard-stop prevents the initial inappropriate order, enforcing diagnostic stewardship guidelines.
Preventing the test prevents the false-positive diagnosis of colonization as active infection, thereby protecting the patient from unnecessary antibiotics and correcting the inflated quality metric.

Key Concept

Diagnostic stewardship in Clostridioides difficile testing to differentiate active infection from asymptomatic colonization.
Rate this question